Star Combo to Acquire 51% Of Inature; Increases Healthcare Product and Sales Footprints In China

  • Nov 18, 2019 AEDT
  • Team Kalkine

Star Combo Pharma Limited (ASX: S66) announced that it has entered into an agreement to acquire 51% of Australian Inature Organic Care Pty Limited (Inature) under which it will be able to access new consumer health products in the pre-natal, post-natal and infant markets:

  • Inature will bring a team of sales and marketing workforce and networks that S66 can use for its full brand portfolio.
  • Presently, Inature’s products are available via a set distribution network of 3,000 retail outlets in China.
  • Under the agreement, S66 will manufacture Inature’s consumer health products in its manufacturing facilities in Sydney.

At AEST 1:55 PM, S66 quoted $0.480, down by 7.6%.


All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK